Diago CD, Luaces CA, García VR, Rodríguez PR

Language: Spanish
References: 13
Page: 135-143
PDF size: 56.35 Kb.

ABSTRACT

Introduction: liver diseases occupied the fourth leading cause of incidence in clinical conditions in pregnancy between 15 and 42 weeks, or preterm infants provided intrauterine growth restricted (IUGR) and low Apgar.
Objective: to describe the perinatal result of the pregnant patients with liver diseases.
Methods: A retrospective, descriptive, cross study was conducted at Maternity Hospital in 10 de Octubre Municipality from January 2007 and June 2011. The sample comprised 16 pregnant women with diagnosis of liver disease. The variables considered were age, gestational age at admission and age at delivery, delivery procedure, weight of neonates according their gestational age, neonatal Apgar scores, type of liver disease, causes of caesarean.
Results: 68.8 % were admitted to perinatal care between 37 and 42 weeks and 75 % had intrahepatic cholestasis. At birth, 62.5% were between 37 and 42 weeks of gestation. Caesarean section was the most common delivery procedure. 37.5 % of the infants weighed between 3-10 percentiles with Apgar scores between 6 and 9. 50% had no complications.
Conclusions: The most frequent liver diseases are those characteristic of the pregnancy and intrahepatic cholestasis is one of among them. It was frequently diagnosed at 34-36 weeks. The Caesarean operation is the elected childbirth procedure at 37 to 42 weeks, generally for bad obstetric conditions. Neonates are born ranking 3-10 percentile and Apgar scores from 6 and 9.

REFERENCES

1. Palacios A, Salmerón J, Ruiz. Extremera A. Actualización: Hígado y embarazo. Gastroenterol Hepatol Continuada. 2006;5 (3):1-67.

2. Jenkins JK, Boothy LA. Treatment of itching assocated with intrahepatic cholestasis of pregnancy. Ann Pharmacother. 2008;36(9):1462-5.

3. Protocolos SEGO. Hepatopatía y embarazo. Prog Obstet Ginecol. 2008;51(5):321-6.

4. Doshi S, Zucker S. Liver Emergencies during Pregnancy. Gastroenterology Clinics of North America. 2008;32:1213-27.

5. Santos D, Doblasa PA, López-Torres E, Herrera J. Hepatopatías en la gestación. Clin Invest Gin Obst. 2007;34(1):21-3.

6. Munch S, Korst LM, Hernandez GD, Romero R, Goodwin TM. Health-related quality of life in women with nausea and vomiting of pregnancy: the importance of psychosocial context. J Perinatol. 2011;31(1):10-20.

7. Ballard S. School of Midwifery, Auckland University of Technology, New Zealand.Blood tests for investigating maternal wellbeing. When nausea and vomiting in pregnancy becomes pathological: hyperemesis gravidarum. Pract Midwife. 2011;14(1):37-41.

8. Costero C. Hepatopatía del embarazo. Ginecol obstet Méx. 1993;61(3):66-71.

9. Reyes H, Zapata R, Hernández I, Gotteland M, Sandoval L, Jirón MI, et al. Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of pregnancy? Hepatology. 2006;43:715-22.

10. Jamjute P, Ahmad A, Ghosh T, Banfield P. Liver function test and pregnancy. J Matern Fetal Neonatal Med. 2009;22(3):274-83.

11. Sánchez SE, Gómez DJ, Morales GV. Preclampsia severa, eclampsia, síndrome de Hellp, comportamiento clínico. [revista en Internet] [acceso 19 Sep 2011];(7). Disponible en: http://www.ejournal.unam.mx/rfm/no48-4/RFM48405.pdf.

12. Lozano A, Vargas G, Núñez N, Figueroa E. Cirrosis hepática y de gestación. Revista de Gastroenterología del Perú. 2000;20(1): 15-9.

13. Samada Suárez M, Vasallo Prieto R, Martínez Changüí Y. Embarazo y trasplante hepático en pacientes cubanas. Rev Cubana Obstet Ginecol. 2011;37(1): 22-7